Monday, January 16 , 2017, 11:10 am | Fair 58º



MIT Enterprise Forum to Present ‘Sientra: The Newest Success Story in Santa Barbara’

The MIT Enterprise Forum Central Coast will present “Sientra: The Newest Success Story in Santa Barbara’s Silicone Alley,” from 5 to 8 p.m. Wednesday, Jan. 16 at the Cabrillo Pavilion Arts Center, 1118 E. Cabrillo Blvd. in Santa Barbara.

Online pre-registration is now open. Click here to register online now to receive early-bird discount, available through Monday, Jan. 14. Walk-ins welcome at general admission rate.

The cost is $30 for online registration, or $40 at the door for general admission and $15 for students with ID. Note that the discounted early-bird registration is only applicable to those who register and pay online. No discount will apply to those who register online but choose to pay at door.

Payment methods accepted at door for general admission are cash, checks (made payable to MITEF-CC) and/or credit card (American Express, Visa, MasterCard, Discover).

Rocketing from obscurity to $151 million of investment and FDA approval, come hear founder and CEO Hani Zeini tell the Sientra story.

For many years, the breast implant business was dominated by two Santa Barbara-based companies — Inamed (now part of Allergan) and Mentor (now part of Johnson & Johnson). Following an unconventional path to introducing a new product, Sientra is disrupting the duopoly of breast implant titans.

Zeini will share his experience in launching a medical device company, his unique perspective on hiring and personnel, and the challenges of attracting investors.

Zeini has more than 24 years of relevant health-care experience in pharmaceuticals and medical device industries, and is an 11-year veteran in the aesthetics and plastic surgery market. He previously served as executive vice president of Inamed Aesthetics. He pioneered the concept of the Plastic Surgery Ecosystem™.

Zeini started his career at Dupont Pharmaceuticals, culminating with his role as senior vice president of Global Health Systems. Prior to joining Inamed, Zeini was COO at Acurian, a development stage venture capital backed clinical trials company. Before Acurian, he held the position of president and CEO at, an Internet-based health-care marketplace.

Zeini holds a bachelor’s degree in electrical and computer engineering from the University of Miami. In 2003, he completed the Stanford Executive Program at Stanford University, Graduate School of Business.

Michael Fauver of Buynak, Fauver, Archbald & Spray will serve as moderator.

Support Noozhawk Today

You are an important ally in our mission to deliver clear, objective, high-quality professional news reporting for Santa Barbara, Goleta and the rest of Santa Barbara County. Join the Hawks Club today to help keep Noozhawk soaring.

We offer four membership levels: $5 a month, $10 a month, $25 a month or $1 a week. Payments can be made through PayPal below, or click here for information on recurring credit-card payments.

Thank you for your vital support.

Reader Comments

Noozhawk encourages free expression, regardless of viewpoint, but requires that such expressions be civil in tone, respectful of other commenters and relevant to the stories on which they are posted. We reserve the right to remove any comment for any reason.

By posting on Noozhawk, you:

» Agree not to submit a comment that is abusive, defamatory, disrespectful, illegal, libelous, profane, vulgar or disparaging (whether on the basis of disability, ethnicity, gender, nationality, race, religion, sexual orientation, traits with which people are born, or otherwise).

» Agree not to submit a comment that attacks or threatens another person, threatens or promotes violence, wishes for harm to befall another person, invades another person's privacy or proprietary rights, or uses expletives (including veiled profanity).

» Agree not to stalk or harass another person, dominate the conversation, discourage participation by others, or bait, belittle, bicker with, mock or taunt others.

» Agree not to solicit others. You agree you will not use Noozhawk’s forums to solicit and/or advertise for personal blogs and websites, without Noozhawk’s express written approval.

» Comments with spam or self-promotional links are not allowed. Comments that include links are automatically routed to a Pending queue. Regularly checking it is not a priority of ours.

Daily Noozhawk

Subscribe to Noozhawk's A.M. Report, our free e-Bulletin sent out every day at 4:15 a.m. with Noozhawk's top stories, hand-picked by the editors.

Sign Up Now >